| | |
| PAST TOP PICK | 10.050 | Peter Hodson | (A Top Pick Nov 20/06. Down 27%.) Has a nice little product and they are going through their trials and there is the talk of being a takeout. However, the market just doesn't care. Sold his holdings. | 2007-10-15 | |
| | |
| TOP PICK | 14.010 | Peter Hodson | There were concerns on FDA approval, but he feels these are not major and the drug is good. Expect it will be taken over. | 2006-11-20 | |
| | |
| BUY | 6.650 | Hugh McCauley | Have some excellent drugs. Data is coming out which they hope will be very good in the next 3/6 months. | 2004-05-13 | |
| | |
| DON'T BUY | 6.960 | Andrew McCreath | Had some interesting trial data. Shares have moved up quite nicely, but now priced with good news built-in. Fully valued. | 2004-04-20 | |
| | |
| BUY | 4.700 | Michael Smedley | Has something that is very competitive in arrhythmia. A good one to take a look at. | 2003-09-30 | |
Experts that have talked about Cardio Pharma Corp
Rss Top Picks Feed